Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: First Call Consensus rates PTSC a strong buy
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
First Call Consensus rates PTSC a strong buy
posted on
Jan 25, 2009 03:04PM
I'm not sure when First Call started PTSC coverage but it was recently.